$FGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIBROGEN INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIBROGEN INC. Get notifications about new insider transactions in FIBROGEN INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | FGEN | FIBROGEN INC | Wettig Thane | Chief Commercial Of ... | Payment of Exercise | F | 27.65 | 2,593 | 71,696 | 45,716 | 48.3 K to 45.7 K (-5.37 %) |
Jun 09 2021 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 22.90 | 2,141 | 49,029 | 280,730 | 282.9 K to 280.7 K (-0.76 %) |
May 28 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 20.86 | 7,800 | 162,708 | 7,800 | |
May 28 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Grant | A | 0.00 | 4,700 | 0 | 14,100 | 9.4 K to 14.1 K (+50.00 %) |
May 28 2021 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 20.86 | 7,800 | 162,708 | 7,800 | |
May 28 2021 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 4,700 | 0 | 395,750 | 391.1 K to 395.8 K (+1.20 %) |
May 28 2021 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 20.86 | 7,800 | 162,708 | 7,800 | |
May 28 2021 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Grant | A | 0.00 | 4,700 | 0 | 52,864 | 48.2 K to 52.9 K (+9.76 %) |
Mar 15 2021 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.50 | 6,000 | 21,000 | 0 | |
Mar 15 2021 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 3.50 | 12,000 | 42,000 | 0 | |
Mar 15 2021 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 35.02 | 18,000 | 630,360 | 148,164 | 166.2 K to 148.2 K (-10.83 %) |
Mar 15 2021 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Buy | M | 3.50 | 18,000 | 63,000 | 166,164 | 148.2 K to 166.2 K (+12.15 %) |
Mar 10 2021 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Payment of Exercise | F | 33.37 | 5,221 | 174,225 | 147,346 | 152.6 K to 147.3 K (-3.42 %) |
Mar 10 2021 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 33.37 | 5,657 | 188,774 | 282,187 | 287.8 K to 282.2 K (-1.97 %) |
Mar 10 2021 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Payment of Exercise | F | 33.37 | 5,679 | 189,508 | 166,597 | 172.3 K to 166.6 K (-3.30 %) |
Feb 26 2021 | FGEN | FIBROGEN INC | Wettig Thane | Chief Commercial Of ... | Option Exercise | A | 53.01 | 32,100 | 1,701,621 | 32,100 | |
Feb 26 2021 | FGEN | FIBROGEN INC | Wettig Thane | Chief Commercial Of ... | Grant | A | 0.00 | 16,500 | 0 | 47,150 | 30.7 K to 47.2 K (+53.83 %) |
Feb 26 2021 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Option Exercise | A | 53.01 | 39,900 | 2,115,099 | 39,900 | |
Feb 26 2021 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Grant | A | 0.00 | 20,800 | 0 | 152,567 | 131.8 K to 152.6 K (+15.79 %) |
Feb 26 2021 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | A | 53.01 | 41,700 | 2,210,517 | 41,700 | |
Feb 26 2021 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Grant | A | 0.00 | 21,700 | 0 | 287,844 | 266.1 K to 287.8 K (+8.15 %) |
Feb 26 2021 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Option Exercise | A | 53.01 | 41,700 | 2,210,517 | 41,700 | |
Feb 26 2021 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Grant | A | 0.00 | 21,700 | 0 | 172,276 | 150.6 K to 172.3 K (+14.41 %) |
Feb 26 2021 | FGEN | FIBROGEN INC | Conterno Enrique A | Chief Executive Off ... | Option Exercise | A | 53.01 | 164,000 | 8,693,640 | 164,000 | |
Feb 26 2021 | FGEN | FIBROGEN INC | Conterno Enrique A | Chief Executive Off ... | Grant | A | 0.00 | 82,000 | 0 | 137,273 | 55.3 K to 137.3 K (+148.35 %) |
Feb 19 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 28.65 | 6,000 | 171,900 | 6,000 | |
Feb 19 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 52.93 | 844 | 44,673 | 33,100 | 33.9 K to 33.1 K (-2.49 %) |
Feb 19 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 52.31 | 5,156 | 269,710 | 33,944 | 39.1 K to 33.9 K (-13.19 %) |
Feb 19 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 28.65 | 6,000 | 171,900 | 39,100 | 33.1 K to 39.1 K (+18.13 %) |
Jan 21 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 19.05 | 6,000 | 114,300 | 0 | |
Jan 21 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 43.38 | 6,000 | 260,280 | 33,100 | 39.1 K to 33.1 K (-15.35 %) |
Jan 21 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 19.05 | 6,000 | 114,300 | 39,100 | 33.1 K to 39.1 K (+18.13 %) |
Jan 15 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 19.05 | 5,999 | 114,281 | 6,000 | |
Jan 15 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 40.04 | 5,999 | 240,200 | 33,100 | 39.1 K to 33.1 K (-15.34 %) |
Jan 15 2021 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 19.05 | 5,999 | 114,281 | 39,099 | 33.1 K to 39.1 K (+18.12 %) |
Jan 08 2021 | FGEN | FIBROGEN INC | Conterno Enrique A | Chief Executive Off ... | Payment of Exercise | F | 38.31 | 5,411 | 207,295 | 55,273 | 60.7 K to 55.3 K (-8.92 %) |
Jan 06 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 9.78 | 6,000 | 58,650 | 0 | |
Jan 06 2021 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 9.78 | 6,000 | 58,650 | 15,400 | 9.4 K to 15.4 K (+63.83 %) |
Dec 30 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 19.05 | 1 | 19 | 11,999 | |
Dec 30 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | M | 18.34 | 6,000 | 110,040 | 0 | |
Dec 30 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 41.14 | 100 | 4,114 | 33,100 | 33.2 K to 33.1 K (-0.30 %) |
Dec 30 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Sell | S | 40.39 | 5,901 | 238,341 | 33,200 | 39.1 K to 33.2 K (-15.09 %) |
Dec 30 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 19.05 | 1 | 19 | 39,101 | 39.1 K to 39.1 K (0.00 %) |
Dec 30 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Buy | M | 18.34 | 6,000 | 110,040 | 39,100 | 33.1 K to 39.1 K (+18.13 %) |
Dec 17 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 41.61 | 3,350 | 139,394 | 192,292 | 195.6 K to 192.3 K (-1.71 %) |
Dec 17 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 43.60 | 3,068 | 133,765 | 266,144 | 269.2 K to 266.1 K (-1.14 %) |
Dec 09 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 41.99 | 3,292 | 138,231 | 195,642 | 198.9 K to 195.6 K (-1.65 %) |
Dec 09 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Payment of Exercise | F | 41.99 | 2,728 | 114,549 | 131,767 | 134.5 K to 131.8 K (-2.03 %) |
Dec 09 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 41.99 | 3,014 | 126,558 | 269,212 | 272.2 K to 269.2 K (-1.11 %) |
Dec 09 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Payment of Exercise | F | 41.99 | 3,039 | 127,608 | 150,576 | 153.6 K to 150.6 K (-1.98 %) |
Nov 19 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Option Exercise | M | 14.58 | 7,082 | 103,220 | 0 | |
Nov 19 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Option Exercise | M | 14.58 | 7,082 | 103,220 | 0 | |
Nov 19 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Buy | M | 14.58 | 7,082 | 103,220 | 134,495 | 127.4 K to 134.5 K (+5.56 %) |
Nov 19 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Buy | M | 14.58 | 7,082 | 103,220 | 134,495 | 127.4 K to 134.5 K (+5.56 %) |
Sep 18 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 44.01 | 3,351 | 147,478 | 198,934 | 202.3 K to 198.9 K (-1.66 %) |
Sep 17 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 43.63 | 3,070 | 133,944 | 272,226 | 275.3 K to 272.2 K (-1.12 %) |
Sep 10 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 42.16 | 3,291 | 138,749 | 202,285 | 205.6 K to 202.3 K (-1.60 %) |
Sep 10 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Payment of Exercise | F | 42.16 | 2,728 | 115,012 | 127,413 | 130.1 K to 127.4 K (-2.10 %) |
Sep 10 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 42.16 | 3,014 | 127,070 | 275,296 | 278.3 K to 275.3 K (-1.08 %) |
Sep 10 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Payment of Exercise | F | 42.16 | 3,038 | 128,082 | 153,615 | 156.7 K to 153.6 K (-1.94 %) |
Sep 04 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | M | 18.00 | 10,000 | 180,000 | 42,500 | |
Sep 04 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 50.89 | 10,000 | 508,900 | 205,576 | 215.6 K to 205.6 K (-4.64 %) |
Sep 04 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Buy | M | 18.00 | 10,000 | 180,000 | 215,576 | 205.6 K to 215.6 K (+4.86 %) |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 25.40 | 8,671 | 220,243 | 41,579 | |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 19.39 | 5,696 | 110,445 | 0 | |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 29.66 | 637 | 18,893 | 4,618 | |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 50.91 | 15,004 | 763,854 | 278,310 | 293.3 K to 278.3 K (-5.12 %) |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 25.40 | 8,671 | 220,243 | 293,314 | 284.6 K to 293.3 K (+3.05 %) |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 19.39 | 5,696 | 110,445 | 284,643 | 278.9 K to 284.6 K (+2.04 %) |
Sep 04 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 29.66 | 637 | 18,893 | 278,947 | 278.3 K to 278.9 K (+0.23 %) |
Aug 21 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | M | 5.95 | 6,000 | 35,700 | 0 | |
Aug 21 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Buy | M | 5.95 | 6,000 | 35,700 | 15,400 | 9.4 K to 15.4 K (+63.83 %) |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 18.00 | 3,500 | 63,000 | 0 | |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 19.39 | 3,750 | 72,713 | 5,696 | |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | M | 19.39 | 22,554 | 437,322 | 9,446 | |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 18.00 | 3,500 | 63,000 | 278,310 | 274.8 K to 278.3 K (+1.27 %) |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 19.39 | 3,750 | 72,713 | 274,810 | 271.1 K to 274.8 K (+1.38 %) |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 48.00 | 22,554 | 1,082,592 | 271,060 | 293.6 K to 271.1 K (-7.68 %) |
Aug 11 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Buy | M | 19.39 | 22,554 | 437,322 | 293,614 | 271.1 K to 293.6 K (+8.32 %) |
Aug 07 2020 | FGEN | FIBROGEN INC | Cravatt Benjamin | Director | Option Exercise | A | 42.65 | 10,400 | 443,560 | 10,400 | |
Aug 07 2020 | FGEN | FIBROGEN INC | Cravatt Benjamin | Director | Option Exercise | A | 42.65 | 6,496 | 277,054 | 6,496 | |
Aug 07 2020 | FGEN | FIBROGEN INC | Cravatt Benjamin | Director | Grant | A | 0.00 | 3,914 | 0 | 3,914 | 0 to 3.9 K |
Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Option Exercise | A | 42.65 | 10,400 | 443,560 | 10,400 | |
Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Option Exercise | A | 42.65 | 6,496 | 277,054 | 6,496 | |
Aug 07 2020 | FGEN | FIBROGEN INC | Brennan Aoife | Director | Grant | A | 0.00 | 3,914 | 0 | 3,914 | 0 to 3.9 K |
Jul 28 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 42.35 | 3,351 | 141,915 | 205,576 | 208.9 K to 205.6 K (-1.60 %) |
Jul 28 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Sell | S | 42.35 | 3,351 | 141,915 | 205,576 | 208.9 K to 205.6 K (-1.60 %) |
Jun 24 2020 | FGEN | FIBROGEN INC | Wettig Thane | Chief Commercial Of ... | Option Exercise | A | 42.08 | 90,000 | 3,787,200 | 90,000 | |
Jun 24 2020 | FGEN | FIBROGEN INC | Wettig Thane | Chief Commercial Of ... | Grant | A | 0.00 | 30,000 | 0 | 30,600 | 600 to 30.6 K (+5,000.00 %) |
Jun 18 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Sell | S | 39.68 | 3,928 | 155,863 | 271,060 | 275 K to 271.1 K (-1.43 %) |
Jun 12 2020 | FGEN | FIBROGEN INC | Conterno Enrique A | Chief Executive Off ... | Buy | P | 35.28 | 19,800 | 698,599 | 27,800 | 8 K to 27.8 K (+247.50 %) |
Jun 12 2020 | FGEN | FIBROGEN INC | Conterno Enrique A | Chief Executive Off ... | Buy | P | 36.29 | 8,000 | 290,282 | 8,000 | 0 to 8 K |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 19.05 | 12,000 | 228,600 | 0 | |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 28.65 | 12,000 | 343,800 | 0 | |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 19.05 | 12,000 | 228,600 | 96,100 | 84.1 K to 96.1 K (+14.27 %) |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 28.65 | 12,000 | 343,800 | 84,100 | 72.1 K to 84.1 K (+16.64 %) |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 19.05 | 12,000 | 228,600 | 0 | |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | M | 28.65 | 12,000 | 343,800 | 0 | |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 19.05 | 12,000 | 228,600 | 96,100 | 84.1 K to 96.1 K (+14.27 %) |
Jun 11 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Buy | M | 28.65 | 12,000 | 343,800 | 84,100 | 72.1 K to 84.1 K (+16.64 %) |
Jun 10 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Payment of Exercise | F | 33.61 | 3,038 | 102,107 | 156,653 | 159.7 K to 156.7 K (-1.90 %) |
Jun 10 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Payment of Exercise | F | 33.61 | 2,156 | 72,463 | 274,988 | 277.1 K to 275 K (-0.78 %) |
Jun 10 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 33.61 | 3,292 | 110,644 | 208,927 | 212.2 K to 208.9 K (-1.55 %) |
Jun 10 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Payment of Exercise | F | 33.61 | 2,728 | 91,688 | 130,141 | 132.9 K to 130.1 K (-2.05 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Schoeneck James A | Director | Grant | A | 0.00 | 4,700 | 0 | 9,400 | 4.7 K to 9.4 K (+100.00 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Rosenkranz Roberto Pedro | Director | Grant | A | 0.00 | 4,700 | 0 | 72,100 | 67.4 K to 72.1 K (+6.97 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | RIGGS RORY B | Director | Grant | A | 0.00 | 4,700 | 0 | 391,050 | 386.4 K to 391.1 K (+1.22 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Lema Gerald | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Lema Gerald | Director | Grant | A | 0.00 | 4,700 | 0 | 9,400 | 4.7 K to 9.4 K (+100.00 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Kurkijarvi Kalevi | Director | Grant | A | 0.00 | 4,700 | 0 | 33,100 | 28.4 K to 33.1 K (+16.55 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Grant | A | 0.00 | 4,700 | 0 | 148,164 | 143.5 K to 148.2 K (+3.28 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Ho Maykin | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Ho Maykin | Director | Grant | A | 0.00 | 4,700 | 0 | 11,255 | 6.6 K to 11.3 K (+71.70 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Henderson Jeffrey William | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Henderson Jeffrey William | Director | Grant | A | 0.00 | 4,700 | 0 | 13,100 | 8.4 K to 13.1 K (+55.95 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | EDWARDS JEFFREY L | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | EDWARDS JEFFREY L | Director | Grant | A | 0.00 | 4,700 | 0 | 13,100 | 8.4 K to 13.1 K (+55.95 %) |
Jun 08 2020 | FGEN | FIBROGEN INC | Blaug Suzanne | Director | Option Exercise | A | 32.69 | 7,800 | 254,982 | 7,800 | |
Jun 08 2020 | FGEN | FIBROGEN INC | Blaug Suzanne | Director | Grant | A | 0.00 | 4,700 | 0 | 9,348 | 4.6 K to 9.3 K (+101.12 %) |
Mar 23 2020 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 2.90 | 6,000 | 17,400 | 0 | |
Mar 23 2020 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Option Exercise | M | 2.90 | 12,000 | 34,800 | 0 | |
Mar 23 2020 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Sell | S | 23.17 | 18,000 | 417,074 | 143,464 | 161.5 K to 143.5 K (-11.15 %) |
Mar 23 2020 | FGEN | FIBROGEN INC | KEARNS THOMAS F JR | Director | Buy | M | 2.90 | 18,000 | 52,200 | 161,464 | 143.5 K to 161.5 K (+12.55 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Option Exercise | M | 25.40 | 7,345 | 186,563 | 34,719 | |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Option Exercise | M | 25.40 | 400 | 10,160 | 42,064 | |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Option Exercise | A | 26.41 | 66,250 | 1,749,663 | 66,250 | |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Sell | S | 26.08 | 6,215 | 162,087 | 159,013 | 165.2 K to 159 K (-3.76 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Sell | S | 25.32 | 830 | 21,016 | 165,228 | 166.1 K to 165.2 K (-0.50 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Sell | S | 23.93 | 300 | 7,179 | 166,058 | 166.4 K to 166.1 K (-0.18 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Buy | M | 25.40 | 7,345 | 186,563 | 166,358 | 159 K to 166.4 K (+4.62 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Sell | S | 25.68 | 1,500 | 38,520 | 159,013 | 160.5 K to 159 K (-0.93 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Sell | S | 24.56 | 1,500 | 36,840 | 160,513 | 162 K to 160.5 K (-0.93 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Sell | S | 23.69 | 905 | 21,439 | 162,013 | 162.9 K to 162 K (-0.56 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Buy | M | 25.40 | 400 | 10,160 | 162,918 | 162.5 K to 162.9 K (+0.25 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Grant | A | 0.00 | 40,000 | 0 | 162,518 | 122.5 K to 162.5 K (+32.65 %) |
Mar 19 2020 | FGEN | FIBROGEN INC | Chung Christine | SVP, China Operatio ... | Payment of Exercise | F | 39.71 | 10,126 | 402,103 | 122,518 | 132.6 K to 122.5 K (-7.63 %) |
Mar 18 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | A | 26.41 | 75,000 | 1,980,750 | 75,000 | |
Mar 18 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Option Exercise | M | 19.39 | 3,750 | 72,713 | 56,250 | |
Mar 18 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Grant | A | 0.00 | 45,000 | 0 | 211,541 | 166.5 K to 211.5 K (+27.02 %) |
Mar 18 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Buy | M | 19.39 | 3,750 | 72,713 | 166,541 | 162.8 K to 166.5 K (+2.30 %) |
Mar 18 2020 | FGEN | FIBROGEN INC | Yu K Peony | Chief Medical Offic ... | Payment of Exercise | F | 39.71 | 9,826 | 390,190 | 162,791 | 172.6 K to 162.8 K (-5.69 %) |
Mar 18 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Option Exercise | A | 26.41 | 62,500 | 1,650,625 | 62,500 | |
Mar 18 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Grant | A | 0.00 | 37,500 | 0 | 132,191 | 94.7 K to 132.2 K (+39.60 %) |
Mar 18 2020 | FGEN | FIBROGEN INC | Kouchakji Elias | SVP, Clinical Dev, ... | Payment of Exercise | F | 39.71 | 6,525 | 259,108 | 94,691 | 101.2 K to 94.7 K (-6.45 %) |
Mar 18 2020 | FGEN | FIBROGEN INC | Cotroneo Pat | SVP, Finance and CF ... | Option Exercise | A | 26.41 | 66,250 | 1,749,663 | 66,250 |